![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 7, 4081-4088, February 13, 1998
,
,
,
, and
¶
From the Departments of We recently reported that macrophages
and fibroblasts secrete a Zn2+-dependent
sphingomyelinase (S-SMase), which, like lysosomal SMase, is a product
of the acid SMase gene. S-SMase may cause subendothelial retention and
aggregation of lipoproteins during atherogenesis, and the acid SMase
gene has been implicated in ceramide-mediated cell signaling,
especially involving apoptosis of endothelial cells. Because of the
central importance of the endothelium in each of these processes, we
now sought to examine the secretion and regulation of S-SMase by
vascular endothelial cells. Herein we show that cultured human coronary
artery and umbilical vein endothelial cells secrete massive amounts of
S-SMase (up to 20-fold more than macrophages). Moreover, whereas
S-SMase secreted by macrophages and fibroblasts is almost totally
dependent on the addition of exogenous Zn2+,
endothelium-derived S-SMase was partially active even in the absence of
added Zn2+. Secretion of S-SMase by endothelial cells
occurred both apically and basolaterally, suggesting an endothelial
contribution to both serum and arterial wall SMase. When endothelial
cells were incubated with inflammatory cytokines, such as
interleukin-1
Medicine and ¶ Anatomy & Cell Biology, Columbia University, New York, New York 10032, ** Berlex
Biosciences, Richmond, California 94804, and the

Dorrance H. Hamilton Research Laboratories,
Division of Endocrinology, Diabetes, and Metabolic Diseases, Thomas
Jefferson University, Philadelphia, Pennsylvania 19107
and interferon-
, S-SMase secretion by endothelial
cells was increased 2-3-fold above the already high level of basal
secretion, whereas lysosomal SMase activity was decreased. The
mechanism of interleukin-1
-stimulated secretion appears to be
through increased routing of a SMase precursor protein through the
secretory pathway. In summary, endothelial cells are a rich and
regulatable source of enzymatically active S-SMase, suggesting
physiologic and pathophysiologic roles for this enzyme.
This article has been cited by other articles:
![]() |
C. Garnacho, R. Dhami, E. Simone, T. Dziubla, J. Leferovich, E. H. Schuchman, V. Muzykantov, and S. Muro Delivery of Acid Sphingomyelinase in Normal and Niemann-Pick Disease Mice Using Intercellular Adhesion Molecule-1-Targeted Polymer Nanocarriers J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 400 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. He, T. A. Luster, and P. E. Thorpe Radiation-Enhanced Vascular Targeting of Human Lung Cancers in Mice with a Monoclonal Antibody That Binds Anionic Phospholipids Clin. Cancer Res., September 1, 2007; 13(17): 5211 - 5218. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Doehner, A. C. Bunck, M. Rauchhaus, S. von Haehling, F. M. Brunkhorst, M. Cicoira, C. Tschope, P. Ponikowski, R. A. Claus, and S. D. Anker Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow Eur. Heart J., April 1, 2007; 28(7): 821 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tani, Y. Igarashi, and M. Ito Involvement of Neutral Ceramidase in Ceramide Metabolism at the Plasma Membrane and in Extracellular Milieu J. Biol. Chem., November 4, 2005; 280(44): 36592 - 36600. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tani, T. Sano, M. Ito, and Y. Igarashi Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets J. Lipid Res., November 1, 2005; 46(11): 2458 - 2467. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Mintzer, K. C. Appell, A. Cole, A. Johns, R. Pagila, M. A. Polokoff, I. Tabas, R. M. Snider, and J. A. Meurer-Ogden A Novel High-Throughput Screening Format to Identify Inhibitors of Secreted Acid Sphingomyelinase J Biomol Screen, April 1, 2005; 10(3): 225 - 234. [Abstract] [PDF] |
||||
![]() |
M. Seto, M. Whitlow, M. A. McCarrick, S. Srinivasan, Y. Zhu, R. Pagila, R. Mintzer, D. Light, A. Johns, and J. A. Meurer-Ogden A model of the acid sphingomyelinase phosphoesterase domain based on its remote structural homolog purple acid phosphatase Protein Sci., December 1, 2004; 13(12): 3172 - 3186. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-y. Morita, M. Kawabe, A. Sakurai, K. Okuhira, A. Vertut-Doi, M. Nakano, and T. Handa Ceramide in Lipid Particles Enhances Heparan Sulfate Proteoglycan and Low Density Lipoprotein Receptor-related Protein-mediated Uptake by Macrophages J. Biol. Chem., June 4, 2004; 279(23): 24355 - 24361. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Boyanovsky, A. Karakashian, K. King, N. Giltiay, and M. Nikolova-Karakashian Uptake and Metabolism of Low Density Lipoproteins with Elevated Ceramide Content by Human Microvascular Endothelial Cells: IMPLICATIONS FOR THE REGULATION OF APOPTOSIS J. Biol. Chem., July 11, 2003; 278(29): 26992 - 26999. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Garcia-Barros, F. Paris, C. Cordon-Cardo, D. Lyden, S. Rafii, A. Haimovitz-Friedman, Z. Fuks, and R. Kolesnick Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis Science, May 16, 2003; 300(5622): 1155 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Drobnik, G. Liebisch, F.-X. Audebert, D. Frohlich, T. Gluck, P. Vogel, G. Rothe, and G. Schmitz Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients J. Lipid Res., April 1, 2003; 44(4): 754 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tani, H. Iida, and M. Ito O-Glycosylation of Mucin-like Domain Retains the Neutral Ceramidase on the Plasma Membranes as a Type II Integral Membrane Protein J. Biol. Chem., March 14, 2003; 278(12): 10523 - 10530. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Devlin, G. Kuriakose, E. Hirsch, and I. Tabas Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size PNAS, April 30, 2002; 99(9): 6280 - 6285. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Paris, Z. Fuks, A. Kang, P. Capodieci, G. Juan, D. Ehleiter, A. Haimovitz-Friedman, C. Cordon-Cardo, and R. Kolesnick Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice Science, July 13, 2001; 293(5528): 293 - 297. [Abstract] [Full Text] |
||||
![]() |
J. R. Guyton Phospholipid Hydrolytic Enzymes in a 'Cesspool' of Arterial Intimal Lipoproteins : A Mechanism for Atherogenic Lipid Accumulation Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 884 - 886. [Full Text] [PDF] |
||||
![]() |
I. Spyridopoulos, P. Mayer, K. S. Shook, D. I. Axel, R. Viebahn, and K. R. Karsch Loss of cyclin A and G1-cell cycle arrest are a prerequisite of ceramide-induced toxicity in human arterial endothelial cells Cardiovasc Res, April 1, 2001; 50(1): 97 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Öörni, M. O. Pentikäinen, M. Ala-Korpela, and P. T. Kovanen Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions J. Lipid Res., November 1, 2000; 41(11): 1703 - 1714. [Abstract] [Full Text] |
||||
![]() |
E. Gulbins, A. Jekle, K. Ferlinz, H. Grassme, and F. Lang Physiology of apoptosis Am J Physiol Renal Physiol, October 1, 2000; 279(4): F605 - F615. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marathe, S. R.P. Miranda, C. Devlin, A. Johns, G. Kuriakose, K. J. Williams, E. H. Schuchman, and I. Tabas Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function Hum. Mol. Genet., August 12, 2000; 9(13): 1967 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Wong, B. Xie, N. Beatini, P. Phu, S. Marathe, A. Johns, P. W. Gold, E. Hirsch, K. J. Williams, J. Licinio, et al. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: A possible link between inflammatory cytokines and atherogenesis PNAS, July 5, 2000; (2000) 150098097. [Abstract] [Full Text] |
||||
![]() |
W. Pruzanski, E. Stefanski, F. C. de Beer, M. C. de Beer, A. Ravandi, and A. Kuksis Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins J. Lipid Res., July 1, 2000; 41(7): 1035 - 1047. [Abstract] [Full Text] |
||||
![]() |
J. M. Holopainen, O. P. Medina, A. J. Metso, and P. K. J. Kinnunen Sphingomyelinase Activity Associated with Human Plasma Low Density Lipoprotein. POSSIBLE FUNCTIONAL IMPLICATIONS J. Biol. Chem., May 26, 2000; 275(22): 16484 - 16489. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marathe, G. Kuriakose, K. J. Williams, and I. Tabas Sphingomyelinase, an Enzyme Implicated in Atherogenesis, Is Present in Atherosclerotic Lesions and Binds to Specific Components of the Subendothelial Extracellular Matrix Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2648 - 2658. [Abstract] [Full Text] [PDF] |
||||
![]() |
Rosie Xing and R. Kolesnick Stress signaling of apoptosis via ceramide and c-jun kinase Innate Immunity, August 1, 1999; 5(4): 216 - 221. [Abstract] [PDF] |
||||
![]() |
H. Vesper, E.-M. Schmelz, M. N. Nikolova-Karakashian, D. L. Dillehay, D. V. Lynch, and A. H. Merrill Jr. Sphingolipids in Food and the Emerging Importance of Sphingolipids to Nutrition J. Nutr., July 1, 1999; 129(7): 1239 - 1250. [Abstract] [Full Text] |
||||
![]() |
T. Langmann, C. Buechler, S. Ries, A. Schaeffler, C. Aslanidis, M. Schuierer, M. Weiler, K. Sandhoff, P. J. de Jong, and G. Schmitz Transcription factors Sp1 and AP-2 mediate induction of acid sphingomyelinase during monocytic differentiation J. Lipid Res., May 1, 1999; 40(5): 870 - 880. [Abstract] [Full Text] |
||||
![]() |
K. Oorni, J. K. Hakala, A. Annila, M. Ala-Korpela, and P. T. Kovanen Sphingomyelinase Induces Aggregation and Fusion, but Phospholipase A2 Only Aggregation, of Low Density Lipoprotein (LDL) Particles. TWO DISTINCT MECHANISMS LEADING TO INCREASED BINDING STRENGTH OF LDL TO HUMAN AORTIC PROTEOGLYCANS J. Biol. Chem., October 30, 1998; 273(44): 29127 - 29134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Schissel, G. A. Keesler, E. H. Schuchman, K. J. Williams, and I. Tabas The Cellular Trafficking and Zinc Dependence of Secretory and Lysosomal Sphingomyelinase, Two Products of the Acid Sphingomyelinase Gene J. Biol. Chem., July 17, 1998; 273(29): 18250 - 18259. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lin, M. O. Hengartner, and R. Kolesnick Caenorhabditis elegans Contains Two Distinct Acid Sphingomyelinases J. Biol. Chem., June 5, 1998; 273(23): 14374 - 14379. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Khelef, X. Buton, N. Beatini, H. Wang, V. Meiner, T.-Y. Chang, R. V. Farese Jr., F. R. Maxfield, and I. Tabas Immunolocalization of Acyl-Coenzyme A:Cholesterol O-Acyltransferase in Macrophages J. Biol. Chem., May 1, 1998; 273(18): 11218 - 11224. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kirschnek, F. Paris, M. Weller, H. Grassme, K. Ferlinz, A. Riehle, Z. Fuks, R. Kolesnick, and E. Gulbins CD95-mediated Apoptosis in Vivo Involves Acid Sphingomyelinase J. Biol. Chem., August 25, 2000; 275(35): 27316 - 27323. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ancellin, C. Colmont, J. Su, Q. Li, N. Mittereder, S.-S. Chae, S. Stefansson, G. Liau, and T. Hla Extracellular Export of Sphingosine Kinase-1 Enzyme. SPHINGOSINE 1-PHOSPHATE GENERATION AND THE INDUCTION OF ANGIOGENIC VASCULAR MATURATION J. Biol. Chem., February 15, 2002; 277(8): 6667 - 6675. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Wong, B. Xie, N. Beatini, P. Phu, S. Marathe, A. Johns, P. W. Gold, E. Hirsch, K. J. Williams, J. Licinio, et al. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: A possible link between inflammatory cytokines and atherogenesis PNAS, July 18, 2000; 97(15): 8681 - 8686. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |